The endogenous cannabinoid, anandamide regulates anterior pituitary secretion in vitro

T. Wenger, Khalid A. Jamali, Christian Juanéda, Ernö Bácsy, Gérard Tramu

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The present study was aimed to test whether the endogenous ligand for the cannabinoid receptor, anandamide (ANA) could produce direct effects on anterior pituitary (AP) hormone secretion in vitro. AP cells, dispersed in Krebs-Ringer, were treated with either (1) different concentrations of ANA, (2) with ANA after pre-treatment with the selective central cannabinoid receptor (CB1) antagonist, SR 141716 (SR) or (3) with SR alone. After 30 min of incubation the luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), adrenocorticotroph hormone (ACTH) as well as growth hormone (GH), were measured in the culture media. All these hormone levels were affected, with the exception of FSH, which did not change after the treatment. LH and PRL levels were decreased while ACTH and GH increased. The LH and PRL decrease were prevented by SR. SR did not antagonize the stimulatory effect exerted by ANA on ACTH and GH release from AP cells. We postulate that ANA inhibits or activates the release and/or synthesis of AP hormones. This activation may occur via another postulated (CBx) receptor for which SR is not an effective antagonist. The results indicate that ANA may influence AP hormone secretion, acting directly on the gland.

Original languageEnglish
Pages (from-to)59-64
Number of pages6
JournalAddiction Biology
Volume5
Issue number1
DOIs
Publication statusPublished - 2000

Fingerprint

Cannabinoids
Anterior Pituitary Hormones
Luteinizing Hormone
Hormones
Prolactin
Growth Hormone
rimonabant
Follicle Stimulating Hormone
Cannabinoid Receptor Antagonists
Cannabinoid Receptor CB1
Cannabinoid Receptors
Culture Media
In Vitro Techniques
anandamide
Ligands

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

The endogenous cannabinoid, anandamide regulates anterior pituitary secretion in vitro. / Wenger, T.; Jamali, Khalid A.; Juanéda, Christian; Bácsy, Ernö; Tramu, Gérard.

In: Addiction Biology, Vol. 5, No. 1, 2000, p. 59-64.

Research output: Contribution to journalArticle

Wenger, T. ; Jamali, Khalid A. ; Juanéda, Christian ; Bácsy, Ernö ; Tramu, Gérard. / The endogenous cannabinoid, anandamide regulates anterior pituitary secretion in vitro. In: Addiction Biology. 2000 ; Vol. 5, No. 1. pp. 59-64.
@article{73f0eb8530884981938ab4ab0867e275,
title = "The endogenous cannabinoid, anandamide regulates anterior pituitary secretion in vitro",
abstract = "The present study was aimed to test whether the endogenous ligand for the cannabinoid receptor, anandamide (ANA) could produce direct effects on anterior pituitary (AP) hormone secretion in vitro. AP cells, dispersed in Krebs-Ringer, were treated with either (1) different concentrations of ANA, (2) with ANA after pre-treatment with the selective central cannabinoid receptor (CB1) antagonist, SR 141716 (SR) or (3) with SR alone. After 30 min of incubation the luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), adrenocorticotroph hormone (ACTH) as well as growth hormone (GH), were measured in the culture media. All these hormone levels were affected, with the exception of FSH, which did not change after the treatment. LH and PRL levels were decreased while ACTH and GH increased. The LH and PRL decrease were prevented by SR. SR did not antagonize the stimulatory effect exerted by ANA on ACTH and GH release from AP cells. We postulate that ANA inhibits or activates the release and/or synthesis of AP hormones. This activation may occur via another postulated (CBx) receptor for which SR is not an effective antagonist. The results indicate that ANA may influence AP hormone secretion, acting directly on the gland.",
author = "T. Wenger and Jamali, {Khalid A.} and Christian Juan{\'e}da and Ern{\"o} B{\'a}csy and G{\'e}rard Tramu",
year = "2000",
doi = "10.1080/13556210071270",
language = "English",
volume = "5",
pages = "59--64",
journal = "Addiction Biology",
issn = "1355-6215",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - The endogenous cannabinoid, anandamide regulates anterior pituitary secretion in vitro

AU - Wenger, T.

AU - Jamali, Khalid A.

AU - Juanéda, Christian

AU - Bácsy, Ernö

AU - Tramu, Gérard

PY - 2000

Y1 - 2000

N2 - The present study was aimed to test whether the endogenous ligand for the cannabinoid receptor, anandamide (ANA) could produce direct effects on anterior pituitary (AP) hormone secretion in vitro. AP cells, dispersed in Krebs-Ringer, were treated with either (1) different concentrations of ANA, (2) with ANA after pre-treatment with the selective central cannabinoid receptor (CB1) antagonist, SR 141716 (SR) or (3) with SR alone. After 30 min of incubation the luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), adrenocorticotroph hormone (ACTH) as well as growth hormone (GH), were measured in the culture media. All these hormone levels were affected, with the exception of FSH, which did not change after the treatment. LH and PRL levels were decreased while ACTH and GH increased. The LH and PRL decrease were prevented by SR. SR did not antagonize the stimulatory effect exerted by ANA on ACTH and GH release from AP cells. We postulate that ANA inhibits or activates the release and/or synthesis of AP hormones. This activation may occur via another postulated (CBx) receptor for which SR is not an effective antagonist. The results indicate that ANA may influence AP hormone secretion, acting directly on the gland.

AB - The present study was aimed to test whether the endogenous ligand for the cannabinoid receptor, anandamide (ANA) could produce direct effects on anterior pituitary (AP) hormone secretion in vitro. AP cells, dispersed in Krebs-Ringer, were treated with either (1) different concentrations of ANA, (2) with ANA after pre-treatment with the selective central cannabinoid receptor (CB1) antagonist, SR 141716 (SR) or (3) with SR alone. After 30 min of incubation the luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), adrenocorticotroph hormone (ACTH) as well as growth hormone (GH), were measured in the culture media. All these hormone levels were affected, with the exception of FSH, which did not change after the treatment. LH and PRL levels were decreased while ACTH and GH increased. The LH and PRL decrease were prevented by SR. SR did not antagonize the stimulatory effect exerted by ANA on ACTH and GH release from AP cells. We postulate that ANA inhibits or activates the release and/or synthesis of AP hormones. This activation may occur via another postulated (CBx) receptor for which SR is not an effective antagonist. The results indicate that ANA may influence AP hormone secretion, acting directly on the gland.

UR - http://www.scopus.com/inward/record.url?scp=0033966238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033966238&partnerID=8YFLogxK

U2 - 10.1080/13556210071270

DO - 10.1080/13556210071270

M3 - Article

VL - 5

SP - 59

EP - 64

JO - Addiction Biology

JF - Addiction Biology

SN - 1355-6215

IS - 1

ER -